Life was improving for Carlos Campos, 72, after starting Ozempic for his type 2 diabetes. When Medicare stopped covering the drug, his blood sugar levels rose, but his diabetes educator helped him access the medication through a patient assistance program. The rise of GLP-1 drugs like Ozempic presents challenges that require a team approach to ensure access and proper treatment. However, barriers to access, affordability, and discontinuation still exist, particularly affecting low-income populations. The team-based model is gaining traction in practices to address these issues and provide comprehensive care for patients with chronic conditions like diabetes and obesity.
Source link
Ozempic’s logistical challenges have doctors look to team approach
